Medical Care
Global Genomic Biomarker Market Research Report 2025
- Sep 06, 25
- ID: 492854
- Pages: 93
- Figures: 96
- Views: 7
This report aims to provide a comprehensive presentation of the global market for Genomic Biomarker, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Genomic Biomarker.
The Genomic Biomarker market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Genomic Biomarker market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Genomic Biomarker companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bio-Rad
Beckman Coulter
Myriad Genetics
Thermo Fisher Scientific
Roche
QIAGEN
Epigenomics
Almac
Pfizer
Human Longevity
ValiRx
Personalis
Eagle Genomics
Empire Genomics
Agilent
Illumina
Segment by Type
Protein Marker
Nucleic Acid Marker
Other
Segment by Application
Hospitals
Diagnostic and research laboratories
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Genomic Biomarker company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The Genomic Biomarker market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Genomic Biomarker market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Genomic Biomarker companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bio-Rad
Beckman Coulter
Myriad Genetics
Thermo Fisher Scientific
Roche
QIAGEN
Epigenomics
Almac
Pfizer
Human Longevity
ValiRx
Personalis
Eagle Genomics
Empire Genomics
Agilent
Illumina
Segment by Type
Protein Marker
Nucleic Acid Marker
Other
Segment by Application
Hospitals
Diagnostic and research laboratories
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Genomic Biomarker company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Genomic Biomarker Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Protein Marker
1.2.3 Nucleic Acid Marker
1.2.4 Other
1.3 Market by Application
1.3.1 Global Genomic Biomarker Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Diagnostic and research laboratories
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Genomic Biomarker Market Perspective (2020-2031)
2.2 Global Genomic Biomarker Growth Trends by Region
2.2.1 Global Genomic Biomarker Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Genomic Biomarker Historic Market Size by Region (2020-2025)
2.2.3 Genomic Biomarker Forecasted Market Size by Region (2026-2031)
2.3 Genomic Biomarker Market Dynamics
2.3.1 Genomic Biomarker Industry Trends
2.3.2 Genomic Biomarker Market Drivers
2.3.3 Genomic Biomarker Market Challenges
2.3.4 Genomic Biomarker Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Genomic Biomarker Players by Revenue
3.1.1 Global Top Genomic Biomarker Players by Revenue (2020-2025)
3.1.2 Global Genomic Biomarker Revenue Market Share by Players (2020-2025)
3.2 Global Genomic Biomarker Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Genomic Biomarker Revenue
3.4 Global Genomic Biomarker Market Concentration Ratio
3.4.1 Global Genomic Biomarker Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Genomic Biomarker Revenue in 2024
3.5 Global Key Players of Genomic Biomarker Head office and Area Served
3.6 Global Key Players of Genomic Biomarker, Product and Application
3.7 Global Key Players of Genomic Biomarker, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Genomic Biomarker Breakdown Data by Type
4.1 Global Genomic Biomarker Historic Market Size by Type (2020-2025)
4.2 Global Genomic Biomarker Forecasted Market Size by Type (2026-2031)
5 Genomic Biomarker Breakdown Data by Application
5.1 Global Genomic Biomarker Historic Market Size by Application (2020-2025)
5.2 Global Genomic Biomarker Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Genomic Biomarker Market Size (2020-2031)
6.2 North America Genomic Biomarker Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Genomic Biomarker Market Size by Country (2020-2025)
6.4 North America Genomic Biomarker Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Genomic Biomarker Market Size (2020-2031)
7.2 Europe Genomic Biomarker Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Genomic Biomarker Market Size by Country (2020-2025)
7.4 Europe Genomic Biomarker Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Genomic Biomarker Market Size (2020-2031)
8.2 Asia-Pacific Genomic Biomarker Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Genomic Biomarker Market Size by Region (2020-2025)
8.4 Asia-Pacific Genomic Biomarker Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Genomic Biomarker Market Size (2020-2031)
9.2 Latin America Genomic Biomarker Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Genomic Biomarker Market Size by Country (2020-2025)
9.4 Latin America Genomic Biomarker Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Genomic Biomarker Market Size (2020-2031)
10.2 Middle East & Africa Genomic Biomarker Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Genomic Biomarker Market Size by Country (2020-2025)
10.4 Middle East & Africa Genomic Biomarker Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bio-Rad
11.1.1 Bio-Rad Company Details
11.1.2 Bio-Rad Business Overview
11.1.3 Bio-Rad Genomic Biomarker Introduction
11.1.4 Bio-Rad Revenue in Genomic Biomarker Business (2020-2025)
11.1.5 Bio-Rad Recent Development
11.2 Beckman Coulter
11.2.1 Beckman Coulter Company Details
11.2.2 Beckman Coulter Business Overview
11.2.3 Beckman Coulter Genomic Biomarker Introduction
11.2.4 Beckman Coulter Revenue in Genomic Biomarker Business (2020-2025)
11.2.5 Beckman Coulter Recent Development
11.3 Myriad Genetics
11.3.1 Myriad Genetics Company Details
11.3.2 Myriad Genetics Business Overview
11.3.3 Myriad Genetics Genomic Biomarker Introduction
11.3.4 Myriad Genetics Revenue in Genomic Biomarker Business (2020-2025)
11.3.5 Myriad Genetics Recent Development
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Details
11.4.2 Thermo Fisher Scientific Business Overview
11.4.3 Thermo Fisher Scientific Genomic Biomarker Introduction
11.4.4 Thermo Fisher Scientific Revenue in Genomic Biomarker Business (2020-2025)
11.4.5 Thermo Fisher Scientific Recent Development
11.5 Roche
11.5.1 Roche Company Details
11.5.2 Roche Business Overview
11.5.3 Roche Genomic Biomarker Introduction
11.5.4 Roche Revenue in Genomic Biomarker Business (2020-2025)
11.5.5 Roche Recent Development
11.6 QIAGEN
11.6.1 QIAGEN Company Details
11.6.2 QIAGEN Business Overview
11.6.3 QIAGEN Genomic Biomarker Introduction
11.6.4 QIAGEN Revenue in Genomic Biomarker Business (2020-2025)
11.6.5 QIAGEN Recent Development
11.7 Epigenomics
11.7.1 Epigenomics Company Details
11.7.2 Epigenomics Business Overview
11.7.3 Epigenomics Genomic Biomarker Introduction
11.7.4 Epigenomics Revenue in Genomic Biomarker Business (2020-2025)
11.7.5 Epigenomics Recent Development
11.8 Almac
11.8.1 Almac Company Details
11.8.2 Almac Business Overview
11.8.3 Almac Genomic Biomarker Introduction
11.8.4 Almac Revenue in Genomic Biomarker Business (2020-2025)
11.8.5 Almac Recent Development
11.9 Pfizer
11.9.1 Pfizer Company Details
11.9.2 Pfizer Business Overview
11.9.3 Pfizer Genomic Biomarker Introduction
11.9.4 Pfizer Revenue in Genomic Biomarker Business (2020-2025)
11.9.5 Pfizer Recent Development
11.10 Human Longevity
11.10.1 Human Longevity Company Details
11.10.2 Human Longevity Business Overview
11.10.3 Human Longevity Genomic Biomarker Introduction
11.10.4 Human Longevity Revenue in Genomic Biomarker Business (2020-2025)
11.10.5 Human Longevity Recent Development
11.11 ValiRx
11.11.1 ValiRx Company Details
11.11.2 ValiRx Business Overview
11.11.3 ValiRx Genomic Biomarker Introduction
11.11.4 ValiRx Revenue in Genomic Biomarker Business (2020-2025)
11.11.5 ValiRx Recent Development
11.12 Personalis
11.12.1 Personalis Company Details
11.12.2 Personalis Business Overview
11.12.3 Personalis Genomic Biomarker Introduction
11.12.4 Personalis Revenue in Genomic Biomarker Business (2020-2025)
11.12.5 Personalis Recent Development
11.13 Eagle Genomics
11.13.1 Eagle Genomics Company Details
11.13.2 Eagle Genomics Business Overview
11.13.3 Eagle Genomics Genomic Biomarker Introduction
11.13.4 Eagle Genomics Revenue in Genomic Biomarker Business (2020-2025)
11.13.5 Eagle Genomics Recent Development
11.14 Empire Genomics
11.14.1 Empire Genomics Company Details
11.14.2 Empire Genomics Business Overview
11.14.3 Empire Genomics Genomic Biomarker Introduction
11.14.4 Empire Genomics Revenue in Genomic Biomarker Business (2020-2025)
11.14.5 Empire Genomics Recent Development
11.15 Agilent
11.15.1 Agilent Company Details
11.15.2 Agilent Business Overview
11.15.3 Agilent Genomic Biomarker Introduction
11.15.4 Agilent Revenue in Genomic Biomarker Business (2020-2025)
11.15.5 Agilent Recent Development
11.16 Illumina
11.16.1 Illumina Company Details
11.16.2 Illumina Business Overview
11.16.3 Illumina Genomic Biomarker Introduction
11.16.4 Illumina Revenue in Genomic Biomarker Business (2020-2025)
11.16.5 Illumina Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Genomic Biomarker Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Protein Marker
1.2.3 Nucleic Acid Marker
1.2.4 Other
1.3 Market by Application
1.3.1 Global Genomic Biomarker Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Diagnostic and research laboratories
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Genomic Biomarker Market Perspective (2020-2031)
2.2 Global Genomic Biomarker Growth Trends by Region
2.2.1 Global Genomic Biomarker Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Genomic Biomarker Historic Market Size by Region (2020-2025)
2.2.3 Genomic Biomarker Forecasted Market Size by Region (2026-2031)
2.3 Genomic Biomarker Market Dynamics
2.3.1 Genomic Biomarker Industry Trends
2.3.2 Genomic Biomarker Market Drivers
2.3.3 Genomic Biomarker Market Challenges
2.3.4 Genomic Biomarker Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Genomic Biomarker Players by Revenue
3.1.1 Global Top Genomic Biomarker Players by Revenue (2020-2025)
3.1.2 Global Genomic Biomarker Revenue Market Share by Players (2020-2025)
3.2 Global Genomic Biomarker Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Genomic Biomarker Revenue
3.4 Global Genomic Biomarker Market Concentration Ratio
3.4.1 Global Genomic Biomarker Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Genomic Biomarker Revenue in 2024
3.5 Global Key Players of Genomic Biomarker Head office and Area Served
3.6 Global Key Players of Genomic Biomarker, Product and Application
3.7 Global Key Players of Genomic Biomarker, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Genomic Biomarker Breakdown Data by Type
4.1 Global Genomic Biomarker Historic Market Size by Type (2020-2025)
4.2 Global Genomic Biomarker Forecasted Market Size by Type (2026-2031)
5 Genomic Biomarker Breakdown Data by Application
5.1 Global Genomic Biomarker Historic Market Size by Application (2020-2025)
5.2 Global Genomic Biomarker Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Genomic Biomarker Market Size (2020-2031)
6.2 North America Genomic Biomarker Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Genomic Biomarker Market Size by Country (2020-2025)
6.4 North America Genomic Biomarker Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Genomic Biomarker Market Size (2020-2031)
7.2 Europe Genomic Biomarker Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Genomic Biomarker Market Size by Country (2020-2025)
7.4 Europe Genomic Biomarker Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Genomic Biomarker Market Size (2020-2031)
8.2 Asia-Pacific Genomic Biomarker Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Genomic Biomarker Market Size by Region (2020-2025)
8.4 Asia-Pacific Genomic Biomarker Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Genomic Biomarker Market Size (2020-2031)
9.2 Latin America Genomic Biomarker Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Genomic Biomarker Market Size by Country (2020-2025)
9.4 Latin America Genomic Biomarker Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Genomic Biomarker Market Size (2020-2031)
10.2 Middle East & Africa Genomic Biomarker Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Genomic Biomarker Market Size by Country (2020-2025)
10.4 Middle East & Africa Genomic Biomarker Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bio-Rad
11.1.1 Bio-Rad Company Details
11.1.2 Bio-Rad Business Overview
11.1.3 Bio-Rad Genomic Biomarker Introduction
11.1.4 Bio-Rad Revenue in Genomic Biomarker Business (2020-2025)
11.1.5 Bio-Rad Recent Development
11.2 Beckman Coulter
11.2.1 Beckman Coulter Company Details
11.2.2 Beckman Coulter Business Overview
11.2.3 Beckman Coulter Genomic Biomarker Introduction
11.2.4 Beckman Coulter Revenue in Genomic Biomarker Business (2020-2025)
11.2.5 Beckman Coulter Recent Development
11.3 Myriad Genetics
11.3.1 Myriad Genetics Company Details
11.3.2 Myriad Genetics Business Overview
11.3.3 Myriad Genetics Genomic Biomarker Introduction
11.3.4 Myriad Genetics Revenue in Genomic Biomarker Business (2020-2025)
11.3.5 Myriad Genetics Recent Development
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Details
11.4.2 Thermo Fisher Scientific Business Overview
11.4.3 Thermo Fisher Scientific Genomic Biomarker Introduction
11.4.4 Thermo Fisher Scientific Revenue in Genomic Biomarker Business (2020-2025)
11.4.5 Thermo Fisher Scientific Recent Development
11.5 Roche
11.5.1 Roche Company Details
11.5.2 Roche Business Overview
11.5.3 Roche Genomic Biomarker Introduction
11.5.4 Roche Revenue in Genomic Biomarker Business (2020-2025)
11.5.5 Roche Recent Development
11.6 QIAGEN
11.6.1 QIAGEN Company Details
11.6.2 QIAGEN Business Overview
11.6.3 QIAGEN Genomic Biomarker Introduction
11.6.4 QIAGEN Revenue in Genomic Biomarker Business (2020-2025)
11.6.5 QIAGEN Recent Development
11.7 Epigenomics
11.7.1 Epigenomics Company Details
11.7.2 Epigenomics Business Overview
11.7.3 Epigenomics Genomic Biomarker Introduction
11.7.4 Epigenomics Revenue in Genomic Biomarker Business (2020-2025)
11.7.5 Epigenomics Recent Development
11.8 Almac
11.8.1 Almac Company Details
11.8.2 Almac Business Overview
11.8.3 Almac Genomic Biomarker Introduction
11.8.4 Almac Revenue in Genomic Biomarker Business (2020-2025)
11.8.5 Almac Recent Development
11.9 Pfizer
11.9.1 Pfizer Company Details
11.9.2 Pfizer Business Overview
11.9.3 Pfizer Genomic Biomarker Introduction
11.9.4 Pfizer Revenue in Genomic Biomarker Business (2020-2025)
11.9.5 Pfizer Recent Development
11.10 Human Longevity
11.10.1 Human Longevity Company Details
11.10.2 Human Longevity Business Overview
11.10.3 Human Longevity Genomic Biomarker Introduction
11.10.4 Human Longevity Revenue in Genomic Biomarker Business (2020-2025)
11.10.5 Human Longevity Recent Development
11.11 ValiRx
11.11.1 ValiRx Company Details
11.11.2 ValiRx Business Overview
11.11.3 ValiRx Genomic Biomarker Introduction
11.11.4 ValiRx Revenue in Genomic Biomarker Business (2020-2025)
11.11.5 ValiRx Recent Development
11.12 Personalis
11.12.1 Personalis Company Details
11.12.2 Personalis Business Overview
11.12.3 Personalis Genomic Biomarker Introduction
11.12.4 Personalis Revenue in Genomic Biomarker Business (2020-2025)
11.12.5 Personalis Recent Development
11.13 Eagle Genomics
11.13.1 Eagle Genomics Company Details
11.13.2 Eagle Genomics Business Overview
11.13.3 Eagle Genomics Genomic Biomarker Introduction
11.13.4 Eagle Genomics Revenue in Genomic Biomarker Business (2020-2025)
11.13.5 Eagle Genomics Recent Development
11.14 Empire Genomics
11.14.1 Empire Genomics Company Details
11.14.2 Empire Genomics Business Overview
11.14.3 Empire Genomics Genomic Biomarker Introduction
11.14.4 Empire Genomics Revenue in Genomic Biomarker Business (2020-2025)
11.14.5 Empire Genomics Recent Development
11.15 Agilent
11.15.1 Agilent Company Details
11.15.2 Agilent Business Overview
11.15.3 Agilent Genomic Biomarker Introduction
11.15.4 Agilent Revenue in Genomic Biomarker Business (2020-2025)
11.15.5 Agilent Recent Development
11.16 Illumina
11.16.1 Illumina Company Details
11.16.2 Illumina Business Overview
11.16.3 Illumina Genomic Biomarker Introduction
11.16.4 Illumina Revenue in Genomic Biomarker Business (2020-2025)
11.16.5 Illumina Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Genomic Biomarker Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Protein Marker
Table 3. Key Players of Nucleic Acid Marker
Table 4. Key Players of Other
Table 5. Global Genomic Biomarker Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Genomic Biomarker Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Genomic Biomarker Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Genomic Biomarker Market Share by Region (2020-2025)
Table 9. Global Genomic Biomarker Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Genomic Biomarker Market Share by Region (2026-2031)
Table 11. Genomic Biomarker Market Trends
Table 12. Genomic Biomarker Market Drivers
Table 13. Genomic Biomarker Market Challenges
Table 14. Genomic Biomarker Market Restraints
Table 15. Global Genomic Biomarker Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Genomic Biomarker Market Share by Players (2020-2025)
Table 17. Global Top Genomic Biomarker Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genomic Biomarker as of 2024)
Table 18. Ranking of Global Top Genomic Biomarker Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Genomic Biomarker Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Genomic Biomarker, Headquarters and Area Served
Table 21. Global Key Players of Genomic Biomarker, Product and Application
Table 22. Global Key Players of Genomic Biomarker, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Genomic Biomarker Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Genomic Biomarker Revenue Market Share by Type (2020-2025)
Table 26. Global Genomic Biomarker Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Genomic Biomarker Revenue Market Share by Type (2026-2031)
Table 28. Global Genomic Biomarker Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Genomic Biomarker Revenue Market Share by Application (2020-2025)
Table 30. Global Genomic Biomarker Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Genomic Biomarker Revenue Market Share by Application (2026-2031)
Table 32. North America Genomic Biomarker Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Genomic Biomarker Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Genomic Biomarker Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Genomic Biomarker Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Genomic Biomarker Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Genomic Biomarker Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Genomic Biomarker Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Genomic Biomarker Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Genomic Biomarker Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Genomic Biomarker Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Genomic Biomarker Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Genomic Biomarker Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Genomic Biomarker Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Genomic Biomarker Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Genomic Biomarker Market Size by Country (2026-2031) & (US$ Million)
Table 47. Bio-Rad Company Details
Table 48. Bio-Rad Business Overview
Table 49. Bio-Rad Genomic Biomarker Product
Table 50. Bio-Rad Revenue in Genomic Biomarker Business (2020-2025) & (US$ Million)
Table 51. Bio-Rad Recent Development
Table 52. Beckman Coulter Company Details
Table 53. Beckman Coulter Business Overview
Table 54. Beckman Coulter Genomic Biomarker Product
Table 55. Beckman Coulter Revenue in Genomic Biomarker Business (2020-2025) & (US$ Million)
Table 56. Beckman Coulter Recent Development
Table 57. Myriad Genetics Company Details
Table 58. Myriad Genetics Business Overview
Table 59. Myriad Genetics Genomic Biomarker Product
Table 60. Myriad Genetics Revenue in Genomic Biomarker Business (2020-2025) & (US$ Million)
Table 61. Myriad Genetics Recent Development
Table 62. Thermo Fisher Scientific Company Details
Table 63. Thermo Fisher Scientific Business Overview
Table 64. Thermo Fisher Scientific Genomic Biomarker Product
Table 65. Thermo Fisher Scientific Revenue in Genomic Biomarker Business (2020-2025) & (US$ Million)
Table 66. Thermo Fisher Scientific Recent Development
Table 67. Roche Company Details
Table 68. Roche Business Overview
Table 69. Roche Genomic Biomarker Product
Table 70. Roche Revenue in Genomic Biomarker Business (2020-2025) & (US$ Million)
Table 71. Roche Recent Development
Table 72. QIAGEN Company Details
Table 73. QIAGEN Business Overview
Table 74. QIAGEN Genomic Biomarker Product
Table 75. QIAGEN Revenue in Genomic Biomarker Business (2020-2025) & (US$ Million)
Table 76. QIAGEN Recent Development
Table 77. Epigenomics Company Details
Table 78. Epigenomics Business Overview
Table 79. Epigenomics Genomic Biomarker Product
Table 80. Epigenomics Revenue in Genomic Biomarker Business (2020-2025) & (US$ Million)
Table 81. Epigenomics Recent Development
Table 82. Almac Company Details
Table 83. Almac Business Overview
Table 84. Almac Genomic Biomarker Product
Table 85. Almac Revenue in Genomic Biomarker Business (2020-2025) & (US$ Million)
Table 86. Almac Recent Development
Table 87. Pfizer Company Details
Table 88. Pfizer Business Overview
Table 89. Pfizer Genomic Biomarker Product
Table 90. Pfizer Revenue in Genomic Biomarker Business (2020-2025) & (US$ Million)
Table 91. Pfizer Recent Development
Table 92. Human Longevity Company Details
Table 93. Human Longevity Business Overview
Table 94. Human Longevity Genomic Biomarker Product
Table 95. Human Longevity Revenue in Genomic Biomarker Business (2020-2025) & (US$ Million)
Table 96. Human Longevity Recent Development
Table 97. ValiRx Company Details
Table 98. ValiRx Business Overview
Table 99. ValiRx Genomic Biomarker Product
Table 100. ValiRx Revenue in Genomic Biomarker Business (2020-2025) & (US$ Million)
Table 101. ValiRx Recent Development
Table 102. Personalis Company Details
Table 103. Personalis Business Overview
Table 104. Personalis Genomic Biomarker Product
Table 105. Personalis Revenue in Genomic Biomarker Business (2020-2025) & (US$ Million)
Table 106. Personalis Recent Development
Table 107. Eagle Genomics Company Details
Table 108. Eagle Genomics Business Overview
Table 109. Eagle Genomics Genomic Biomarker Product
Table 110. Eagle Genomics Revenue in Genomic Biomarker Business (2020-2025) & (US$ Million)
Table 111. Eagle Genomics Recent Development
Table 112. Empire Genomics Company Details
Table 113. Empire Genomics Business Overview
Table 114. Empire Genomics Genomic Biomarker Product
Table 115. Empire Genomics Revenue in Genomic Biomarker Business (2020-2025) & (US$ Million)
Table 116. Empire Genomics Recent Development
Table 117. Agilent Company Details
Table 118. Agilent Business Overview
Table 119. Agilent Genomic Biomarker Product
Table 120. Agilent Revenue in Genomic Biomarker Business (2020-2025) & (US$ Million)
Table 121. Agilent Recent Development
Table 122. Illumina Company Details
Table 123. Illumina Business Overview
Table 124. Illumina Genomic Biomarker Product
Table 125. Illumina Revenue in Genomic Biomarker Business (2020-2025) & (US$ Million)
Table 126. Illumina Recent Development
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
Table 130. Authors List of This Report
List of Figures
Figure 1. Genomic Biomarker Picture
Figure 2. Global Genomic Biomarker Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Genomic Biomarker Market Share by Type: 2024 VS 2031
Figure 4. Protein Marker Features
Figure 5. Nucleic Acid Marker Features
Figure 6. Other Features
Figure 7. Global Genomic Biomarker Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Genomic Biomarker Market Share by Application: 2024 VS 2031
Figure 9. Hospitals Case Studies
Figure 10. Diagnostic and research laboratories Case Studies
Figure 11. Genomic Biomarker Report Years Considered
Figure 12. Global Genomic Biomarker Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Genomic Biomarker Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Genomic Biomarker Market Share by Region: 2024 VS 2031
Figure 15. Global Genomic Biomarker Market Share by Players in 2024
Figure 16. Global Top Genomic Biomarker Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genomic Biomarker as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Genomic Biomarker Revenue in 2024
Figure 18. North America Genomic Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Genomic Biomarker Market Share by Country (2020-2031)
Figure 20. United States Genomic Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Genomic Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Genomic Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Genomic Biomarker Market Share by Country (2020-2031)
Figure 24. Germany Genomic Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Genomic Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Genomic Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Genomic Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Genomic Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Genomic Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Genomic Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Genomic Biomarker Market Share by Region (2020-2031)
Figure 32. China Genomic Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Genomic Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Genomic Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Genomic Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Genomic Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Genomic Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Genomic Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Genomic Biomarker Market Share by Country (2020-2031)
Figure 40. Mexico Genomic Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Genomic Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Genomic Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Genomic Biomarker Market Share by Country (2020-2031)
Figure 44. Turkey Genomic Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Genomic Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Genomic Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Bio-Rad Revenue Growth Rate in Genomic Biomarker Business (2020-2025)
Figure 48. Beckman Coulter Revenue Growth Rate in Genomic Biomarker Business (2020-2025)
Figure 49. Myriad Genetics Revenue Growth Rate in Genomic Biomarker Business (2020-2025)
Figure 50. Thermo Fisher Scientific Revenue Growth Rate in Genomic Biomarker Business (2020-2025)
Figure 51. Roche Revenue Growth Rate in Genomic Biomarker Business (2020-2025)
Figure 52. QIAGEN Revenue Growth Rate in Genomic Biomarker Business (2020-2025)
Figure 53. Epigenomics Revenue Growth Rate in Genomic Biomarker Business (2020-2025)
Figure 54. Almac Revenue Growth Rate in Genomic Biomarker Business (2020-2025)
Figure 55. Pfizer Revenue Growth Rate in Genomic Biomarker Business (2020-2025)
Figure 56. Human Longevity Revenue Growth Rate in Genomic Biomarker Business (2020-2025)
Figure 57. ValiRx Revenue Growth Rate in Genomic Biomarker Business (2020-2025)
Figure 58. Personalis Revenue Growth Rate in Genomic Biomarker Business (2020-2025)
Figure 59. Eagle Genomics Revenue Growth Rate in Genomic Biomarker Business (2020-2025)
Figure 60. Empire Genomics Revenue Growth Rate in Genomic Biomarker Business (2020-2025)
Figure 61. Agilent Revenue Growth Rate in Genomic Biomarker Business (2020-2025)
Figure 62. Illumina Revenue Growth Rate in Genomic Biomarker Business (2020-2025)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Table 1. Global Genomic Biomarker Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Protein Marker
Table 3. Key Players of Nucleic Acid Marker
Table 4. Key Players of Other
Table 5. Global Genomic Biomarker Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Genomic Biomarker Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Genomic Biomarker Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Genomic Biomarker Market Share by Region (2020-2025)
Table 9. Global Genomic Biomarker Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Genomic Biomarker Market Share by Region (2026-2031)
Table 11. Genomic Biomarker Market Trends
Table 12. Genomic Biomarker Market Drivers
Table 13. Genomic Biomarker Market Challenges
Table 14. Genomic Biomarker Market Restraints
Table 15. Global Genomic Biomarker Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Genomic Biomarker Market Share by Players (2020-2025)
Table 17. Global Top Genomic Biomarker Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genomic Biomarker as of 2024)
Table 18. Ranking of Global Top Genomic Biomarker Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Genomic Biomarker Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Genomic Biomarker, Headquarters and Area Served
Table 21. Global Key Players of Genomic Biomarker, Product and Application
Table 22. Global Key Players of Genomic Biomarker, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Genomic Biomarker Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Genomic Biomarker Revenue Market Share by Type (2020-2025)
Table 26. Global Genomic Biomarker Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Genomic Biomarker Revenue Market Share by Type (2026-2031)
Table 28. Global Genomic Biomarker Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Genomic Biomarker Revenue Market Share by Application (2020-2025)
Table 30. Global Genomic Biomarker Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Genomic Biomarker Revenue Market Share by Application (2026-2031)
Table 32. North America Genomic Biomarker Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Genomic Biomarker Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Genomic Biomarker Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Genomic Biomarker Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Genomic Biomarker Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Genomic Biomarker Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Genomic Biomarker Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Genomic Biomarker Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Genomic Biomarker Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Genomic Biomarker Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Genomic Biomarker Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Genomic Biomarker Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Genomic Biomarker Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Genomic Biomarker Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Genomic Biomarker Market Size by Country (2026-2031) & (US$ Million)
Table 47. Bio-Rad Company Details
Table 48. Bio-Rad Business Overview
Table 49. Bio-Rad Genomic Biomarker Product
Table 50. Bio-Rad Revenue in Genomic Biomarker Business (2020-2025) & (US$ Million)
Table 51. Bio-Rad Recent Development
Table 52. Beckman Coulter Company Details
Table 53. Beckman Coulter Business Overview
Table 54. Beckman Coulter Genomic Biomarker Product
Table 55. Beckman Coulter Revenue in Genomic Biomarker Business (2020-2025) & (US$ Million)
Table 56. Beckman Coulter Recent Development
Table 57. Myriad Genetics Company Details
Table 58. Myriad Genetics Business Overview
Table 59. Myriad Genetics Genomic Biomarker Product
Table 60. Myriad Genetics Revenue in Genomic Biomarker Business (2020-2025) & (US$ Million)
Table 61. Myriad Genetics Recent Development
Table 62. Thermo Fisher Scientific Company Details
Table 63. Thermo Fisher Scientific Business Overview
Table 64. Thermo Fisher Scientific Genomic Biomarker Product
Table 65. Thermo Fisher Scientific Revenue in Genomic Biomarker Business (2020-2025) & (US$ Million)
Table 66. Thermo Fisher Scientific Recent Development
Table 67. Roche Company Details
Table 68. Roche Business Overview
Table 69. Roche Genomic Biomarker Product
Table 70. Roche Revenue in Genomic Biomarker Business (2020-2025) & (US$ Million)
Table 71. Roche Recent Development
Table 72. QIAGEN Company Details
Table 73. QIAGEN Business Overview
Table 74. QIAGEN Genomic Biomarker Product
Table 75. QIAGEN Revenue in Genomic Biomarker Business (2020-2025) & (US$ Million)
Table 76. QIAGEN Recent Development
Table 77. Epigenomics Company Details
Table 78. Epigenomics Business Overview
Table 79. Epigenomics Genomic Biomarker Product
Table 80. Epigenomics Revenue in Genomic Biomarker Business (2020-2025) & (US$ Million)
Table 81. Epigenomics Recent Development
Table 82. Almac Company Details
Table 83. Almac Business Overview
Table 84. Almac Genomic Biomarker Product
Table 85. Almac Revenue in Genomic Biomarker Business (2020-2025) & (US$ Million)
Table 86. Almac Recent Development
Table 87. Pfizer Company Details
Table 88. Pfizer Business Overview
Table 89. Pfizer Genomic Biomarker Product
Table 90. Pfizer Revenue in Genomic Biomarker Business (2020-2025) & (US$ Million)
Table 91. Pfizer Recent Development
Table 92. Human Longevity Company Details
Table 93. Human Longevity Business Overview
Table 94. Human Longevity Genomic Biomarker Product
Table 95. Human Longevity Revenue in Genomic Biomarker Business (2020-2025) & (US$ Million)
Table 96. Human Longevity Recent Development
Table 97. ValiRx Company Details
Table 98. ValiRx Business Overview
Table 99. ValiRx Genomic Biomarker Product
Table 100. ValiRx Revenue in Genomic Biomarker Business (2020-2025) & (US$ Million)
Table 101. ValiRx Recent Development
Table 102. Personalis Company Details
Table 103. Personalis Business Overview
Table 104. Personalis Genomic Biomarker Product
Table 105. Personalis Revenue in Genomic Biomarker Business (2020-2025) & (US$ Million)
Table 106. Personalis Recent Development
Table 107. Eagle Genomics Company Details
Table 108. Eagle Genomics Business Overview
Table 109. Eagle Genomics Genomic Biomarker Product
Table 110. Eagle Genomics Revenue in Genomic Biomarker Business (2020-2025) & (US$ Million)
Table 111. Eagle Genomics Recent Development
Table 112. Empire Genomics Company Details
Table 113. Empire Genomics Business Overview
Table 114. Empire Genomics Genomic Biomarker Product
Table 115. Empire Genomics Revenue in Genomic Biomarker Business (2020-2025) & (US$ Million)
Table 116. Empire Genomics Recent Development
Table 117. Agilent Company Details
Table 118. Agilent Business Overview
Table 119. Agilent Genomic Biomarker Product
Table 120. Agilent Revenue in Genomic Biomarker Business (2020-2025) & (US$ Million)
Table 121. Agilent Recent Development
Table 122. Illumina Company Details
Table 123. Illumina Business Overview
Table 124. Illumina Genomic Biomarker Product
Table 125. Illumina Revenue in Genomic Biomarker Business (2020-2025) & (US$ Million)
Table 126. Illumina Recent Development
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
Table 130. Authors List of This Report
List of Figures
Figure 1. Genomic Biomarker Picture
Figure 2. Global Genomic Biomarker Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Genomic Biomarker Market Share by Type: 2024 VS 2031
Figure 4. Protein Marker Features
Figure 5. Nucleic Acid Marker Features
Figure 6. Other Features
Figure 7. Global Genomic Biomarker Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Genomic Biomarker Market Share by Application: 2024 VS 2031
Figure 9. Hospitals Case Studies
Figure 10. Diagnostic and research laboratories Case Studies
Figure 11. Genomic Biomarker Report Years Considered
Figure 12. Global Genomic Biomarker Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Genomic Biomarker Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Genomic Biomarker Market Share by Region: 2024 VS 2031
Figure 15. Global Genomic Biomarker Market Share by Players in 2024
Figure 16. Global Top Genomic Biomarker Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genomic Biomarker as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Genomic Biomarker Revenue in 2024
Figure 18. North America Genomic Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Genomic Biomarker Market Share by Country (2020-2031)
Figure 20. United States Genomic Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Genomic Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Genomic Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Genomic Biomarker Market Share by Country (2020-2031)
Figure 24. Germany Genomic Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Genomic Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Genomic Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Genomic Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Genomic Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Genomic Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Genomic Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Genomic Biomarker Market Share by Region (2020-2031)
Figure 32. China Genomic Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Genomic Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Genomic Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Genomic Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Genomic Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Genomic Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Genomic Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Genomic Biomarker Market Share by Country (2020-2031)
Figure 40. Mexico Genomic Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Genomic Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Genomic Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Genomic Biomarker Market Share by Country (2020-2031)
Figure 44. Turkey Genomic Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Genomic Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Genomic Biomarker Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Bio-Rad Revenue Growth Rate in Genomic Biomarker Business (2020-2025)
Figure 48. Beckman Coulter Revenue Growth Rate in Genomic Biomarker Business (2020-2025)
Figure 49. Myriad Genetics Revenue Growth Rate in Genomic Biomarker Business (2020-2025)
Figure 50. Thermo Fisher Scientific Revenue Growth Rate in Genomic Biomarker Business (2020-2025)
Figure 51. Roche Revenue Growth Rate in Genomic Biomarker Business (2020-2025)
Figure 52. QIAGEN Revenue Growth Rate in Genomic Biomarker Business (2020-2025)
Figure 53. Epigenomics Revenue Growth Rate in Genomic Biomarker Business (2020-2025)
Figure 54. Almac Revenue Growth Rate in Genomic Biomarker Business (2020-2025)
Figure 55. Pfizer Revenue Growth Rate in Genomic Biomarker Business (2020-2025)
Figure 56. Human Longevity Revenue Growth Rate in Genomic Biomarker Business (2020-2025)
Figure 57. ValiRx Revenue Growth Rate in Genomic Biomarker Business (2020-2025)
Figure 58. Personalis Revenue Growth Rate in Genomic Biomarker Business (2020-2025)
Figure 59. Eagle Genomics Revenue Growth Rate in Genomic Biomarker Business (2020-2025)
Figure 60. Empire Genomics Revenue Growth Rate in Genomic Biomarker Business (2020-2025)
Figure 61. Agilent Revenue Growth Rate in Genomic Biomarker Business (2020-2025)
Figure 62. Illumina Revenue Growth Rate in Genomic Biomarker Business (2020-2025)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Outdoor Shed Market Research Report 2025
Sep 09, 25
Global Residential Outdoor Cabinet Market Research Report 2025
Sep 09, 25
Global Outdoor Storage Cabinet Market Research Report 2025
Sep 09, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232